Arrowstreet Capital Limited Partnership decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 6.3% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,165,258 shares of the company’s stock after selling 145,854 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in HCA Healthcare were worth $1,024,687,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also made changes to their positions in HCA. Palisade Asset Management LLC bought a new position in HCA Healthcare during the third quarter valued at approximately $26,000. Ares Financial Consulting LLC bought a new position in shares of HCA Healthcare during the 4th quarter valued at approximately $31,000. JPL Wealth Management LLC bought a new stake in HCA Healthcare in the third quarter worth $33,000. Cedar Mountain Advisors LLC purchased a new stake in HCA Healthcare during the first quarter valued at $33,000. Finally, MCF Advisors LLC grew its stake in shares of HCA Healthcare by 213.0% in the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after buying an additional 49 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.
HCA Healthcare Stock Up 1.4%
Shares of HCA Healthcare stock opened at $376.90 on Friday. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The company has a market capitalization of $83.61 billion, a PE ratio of 12.96, a price-to-earnings-growth ratio of 1.25 and a beta of 1.12. The stock’s fifty day moving average is $387.76 and its two-hundred day moving average is $454.23.
Analyst Ratings Changes
A number of research analysts recently commented on the stock. Raymond James Financial set a $528.00 price target on shares of HCA Healthcare in a report on Tuesday, July 7th. Leerink Partners dropped their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Weiss Ratings lowered HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Cantor Fitzgerald cut their price objective on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research report on Tuesday, July 7th. Finally, Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a report on Tuesday, July 14th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $483.45.
Check Out Our Latest Stock Analysis on HCA Healthcare
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
